ClinicalTrials.govpublic full text
Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients
lymphoid leukemia, myeloid leukemia, monocytic leukemia, myelodysplasia, vitamin c, hematopoietic cell transplant (hct), non-relapse mortality, graft versus host disease (gvhd), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 966616
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.